Shares fell after management admitted that the company wasn't executing as well as hoped.
Shares dropped after the company reported rough second-quarter results and announced a leadership transition.
The cardiovascular disease specialist continues to grow its top line at a breakneck speed.
Shares fall even though the company posted better-than-expected results. What can explain the move?
The niche software provider has rolled out several new services that could help it continue to win its fair share of new business.
The animal diagnostic company continues to turn single-digit revenue growth into big gains on the bottom line.
Shares dropped after the company reported second-quarter results that missed the mark, and cut guidance.
Margin improvements allowed the medical equipment supplier to turn single-digit revenue growth into outsize gains where it counts.
Shares pop after the company reports upbeat second-quarter results and issues bullish guidance.
The medical device maker dials back on its growth projections after another tough quarter.
Upbeat second-quarter results and bullish guidance boost the shares of the provider of digital government services.
The semiconductor supplier's revenue and profits headed in opposite directions, and management sees more of the same ahead.
Shares jumped after the company reported better-than-expected second-quarter results.
Shares sink after the company's earnings come up short and management cuts guidance.
The company's incredible business momentum continues.
Shares jump after the medical device maker reported upbeat second-quarter results. Here's what investors need to know.
Net income took a step backward in the second quarter, as the for-profit hospital conglomerate struggled with expense control.
Shares slump after the company's second-quarter results come up short.
Shares slide after the company reported second-quarter results that missed the mark.
The regional bank continues to crank out steady results and has authorized a new $100 million stock repurchase plan.